SEC Form 3 · accession 0001104659-16-130191
Syros Pharmaceuticals, Inc. · SYRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Perspecta Trust LLC
10% Owner
Period of report
Jun 29, 2016
Accepted (ET)
Jun 29, 2016 · 6:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001556263
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 351,666 | I | Owned by the JEB Syros Trust, of which Perspecta Trust LLC is trustee. |
Table II — derivative securities
No Table II lines on this filing.